Trust is central to pharmaceutical manufacturing. Patients, healthcare providers, and regulators expect medicines to be safe, effective and consistent. While much of this trust is focused on the API, it is equally dependent on the integrity of the excipients. Among these, ethanol plays a particularly critical role due to its multifunctional applications across oral, injectable and topical formulations.
To safeguard this trust, excipients must be produced and controlled under the same rigorous standards applied to APIs. This is the role of Good Manufacturing Practice (GMP) certification.
What GMP Certification Means
GMP is the globally recognised system for ensuring that medicines — and their components — are consistently produced to quality standards appropriate for their intended use. For pharmaceutical products, GMP certification confirms that:
- Manufacturing processes are documented, validated, and controlled
- Raw material sourcing is verified and traceable
- Facilities and equipment meet defined standards of cleanliness and maintenance
- Personnel training is appropriate to ensure consistent compliance
- Quality systems are in place for deviation management, change control, and CAPA (Corrective and Preventive Action)
This level of oversight reduces variability, mitigates contamination risks and provides confidence that the product is fit for intended use.
Beyond GMP – Excipients & EXCiPACT
While GMP for APIs and finished products is well-established, excipients historically received less regulatory scrutiny. This gap has been addressed through initiatives such as EXCiPACT GMP, which specifically extends GMP principles to excipient production.
This scheme provides:
- Independent certification that excipient manufacturers meet defined GMP standards
- Reduced audit burden for pharmaceutical companies, since EXCiPACT GMP certification is globally recognised
- Alignment with regulatory expectations, as MHRA, EMA and FDA increasingly require risk-based supplier qualification for excipients
For ethanol, EXCiPACT GMP certification provides a clear signal that the supplier operates under pharmaceutical-grade quality systems, not industrial commodity standards.
Why Certification Builds Trust
The absence of GMP or similar certification leaves pharma companies exposed to supply chain risks, including:
- Regulatory inspection findings related to inadequate supplier qualification
- Batch failure or recall due to excipient contamination
- Loss of market trust and reputational damage in the event of non-compliance
Conversely, EXCiPACT GMP certification provides assurance across the value chain:
- For regulators: evidence of compliance and reduced risk
- For manufacturers: confidence in excipient quality, lowering audit and testing burden
- For patients: assurance that medicines are safe and consistent
Pharmaceutical trust is not built on APIs alone. It is the result of a robust quality ecosystem that extends to excipients like ethanol. EXCiPACT GMP certification provides the foundation of this trust — transforming ethanol from a commodity into a controlled, compliant material that meets the highest standards of pharmaceutical care.
For ethanol suppliers, GMP certification is not a differentiator; it is an entry requirement for participation in a regulated global market.
Kimia offers a trusted range of solutions for the pharmaceutical industry, with flexible packaging to suit your needs. Our EXCiPACT GMP-certified site also supplies certified Halal and Kosher options, ensuring reliability, quality and security of supply. Explore our full product range here.
